On 3 June 2022, Perfect Holding SA (Perfect Holding) announced the successful completion of its reverse takeover (RTO) transaction with Kinarus AG. The SIX Swiss Exchange listed Perfect Holding has acquired more than 95% of the shares of Kinarus, a privately owned clinical-stage biopharmaceutical company engaged in the development of novel therapeutics for the treatment of viral, respiratory and ophthalmic diseases by way of a share exchange. The new shares of Perfect Holding issued to the Kinarus shareholders in exchange for their Kinarus shares have been admitted for listing and trading on the SIX Swiss Exchange as from 3 June 2022. The RTO process will be completed in the following days with a change of the company’s name from Perfect Holding into Kinarus Therapeutics Holding AG and a move of its seat from Lausanne to Basel.